Doctor Robert Mentz
Duke University School of Medicine, Durham (United States of America)
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis
Event: ESC Congress 2023
Topic: Cardiovascular Pharmacotherapy
Session: Novel targets and treatments for heart diseases and diabetes
In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Diabetes and the heart 2
ESC 365 is supported by
